Journal of Chest Surgery

The Korean Society for Thoracic and Cardiovascular Surgery (대한심장혈관흉부외과학회)
권호 표지
DOI QR코드

DOI QR Code

Outcomes after Biventricular Repair Using a Conduit between the Right Ventricle and Pulmonary Artery in Infancy

  • Dong Hee Jang (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Dong-Hee Kim (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Eun Seok Choi (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Tae-Jin Yun (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Chun Soo Park (Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2023.08.11
  • Accepted : 2023.10.24
  • Published : 2024.01.05
Download PDF
⟨ Previous Next ⟩

Abstract

Background: This study investigated the outcomes of biventricular repair using right ventricle to pulmonary artery (RV-PA) conduit placement in patients aged <1 year. Methods: Patients aged <1 year who underwent biventricular repair using an RV-PA conduit between 2011 and 2020 were included in this study. The outcomes of interest were death from any cause, conduit reintervention, and conduit dysfunction (peak velocity of ≥3.5 m/sec or moderate or severe regurgitation). Results: In total, 141 patients were enrolled. The median age at initial conduit implantation was 6 months. The median conduit diameter z-score was 1.3. The overall 5-year survival rate was 89.6%. In the multivariable analysis, younger age (p=0.006) and longer cardiopulmonary bypass time (p=0.001) were risk factors for overall mortality. During follow-up, 61 patients required conduit reintervention, and conduit dysfunction occurred in 68 patients. The 5-year freedom from conduit reintervention and dysfunction rates were 52.9% and 45.9%, respectively. In the multivariable analysis, a smaller conduit z-score (p<0.001) was a shared risk factor for both conduit reintervention and dysfunction. Analysis of variance demonstrated a nonlinear relationship between the conduit z-score and conduit reintervention or dysfunction. The hazard ratio was lowest in patients with a conduit z-score of 1.3 for reintervention and a conduit z-score of 1.4 for dysfunction. Conclusion: RV-PA conduit placement can be safely performed in infants. A significant number of patients required conduit reintervention and had conduit dysfunction. A slightly oversized conduit with a z-score of 1.3 may reduce the risk of conduit reintervention or dysfunction.

Keywords

References

  1. Willetts RG, Stickley J, Drury NE, et al. Four right ventricle to pulmonary artery conduit types. J Thorac Cardiovasc Surg 2021;162: 1324-33. https://doi.org/10.1016/j.jtcvs.2020.12.144
  2. Alsoufi B. Right ventricle-to-pulmonary artery conduits: do we really have an option? J Thorac Cardiovasc Surg 2016;151:442-3. https://doi.org/10.1016/j.jtcvs.2015.10.100
  3. Saxena A, Salve GG, Betts K, et al. Outcomes following heterotopic placement of right ventricle to pulmonary artery conduits. World J Pediatr Congenit Heart Surg 2021;12:220-9. https://doi.org/10.1177/2150135120975769
  4. Ong K, Boone R, Gao M, et al. Right ventricle to pulmonary artery conduit reoperations in patients with tetralogy of Fallot or pulmonary atresia associated with ventricular septal defect. Am J Cardiol 2013;111:1638-43. https://doi.org/10.1016/j.amjcard.2013.01.337
  5. Dearani JA, Danielson GK, Puga FJ, et al. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg 2003;75:399-411. https://doi.org/10.1016/s0003-4975(02)04547-2
  6. Vitanova K, Cleuziou J, Horer J, et al. Which type of conduit to choose for right ventricular outflow tract reconstruction in patients below 1 year of age? Eur J Cardiothorac Surg 2014;46:961-6. https://doi.org/10.1093/ejcts/ezu080
  7. Caldarone CA, McCrindle BW, Van Arsdell GS, et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg 2000;120:1022-31. https://doi.org/10.1067/mtc.2000.110684
  8. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23. https://doi.org/10.1016/j.echo.2008.11.029
  9. Andersen ND, Turek JW. Commentary: decision-making for right ventricle to pulmonary artery conduit selection: statistical models and clinical practice. J Thorac Cardiovasc Surg 2021;162:1334-5. https://doi.org/10.1016/j.jtcvs.2021.01.018
  10. Prior N, Alphonso N, Arnold P, et al. Bovine jugular vein valved conduit: up to 10 years follow-up. J Thorac Cardiovasc Surg 2011;141:983-7. https://doi.org/10.1016/j.jtcvs.2010.08.037
  11. Shinkawa T, Chipman C, Bozzay T, Tang X, Gossett JM, Imamura M. Outcome of right ventricle to pulmonary artery conduit for biventricular repair. Ann Thorac Surg 2015;99:1357-66. https://doi.org/10.1016/j.athoracsur.2014.07.095
  12. Karamlou T, Blackstone EH, Hawkins JA, et al. Can pulmonary conduit dysfunction and failure be reduced in infants and children less than age 2 years at initial implantation? J Thorac Cardiovasc Surg 2006;132:829-38. https://doi.org/10.1016/j.jtcvs.2006.06.034
  13. Mery CM, Guzman-Pruneda FA, De Leon LE, et al. Risk factors for development of endocarditis and reintervention in patients undergoing right ventricle to pulmonary artery valved conduit placement. J Thorac Cardiovasc Surg 2016;151:432-9, 441. https://doi.org/10.1016/j.jtcvs.2015.10.069
  14. Poynter JA, Eghtesady P, McCrindle BW, et al. Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg 2013;96:1695-702. https://doi.org/10.1016/j.athoracsur.2013.05.074
  15. Askovich B, Hawkins JA, Sower CT, et al. Right ventricle-to-pulmonary artery conduit longevity: is it related to allograft size? Ann Thorac Surg 2007;84:907-12. https://doi.org/10.1016/j.athoracsur.2007.04.104
  16. Barron DJ, Guariento A. Oversize it: valuable advice for larger right ventricle-to-pulmonary artery conduits. Ann Thorac Surg 2021;112:1508. https://doi.org/10.1016/j.athoracsur.2021.02.040
  17. Kim DH, Kwon YK, Choi ES, Kwon BS, Park CS, Yun TJ. Risk factors for early adverse outcomes after bovine jugular vein conduit implantation: influence of oversized conduit on the outcomes. Interact Cardiovasc Thorac Surg 2022;35:ivac197. https://doi.org/10.1093/icvts/ivac197
  18. Miyazaki T, Yamagishi M, Maeda Y, et al. Long-term outcomes of expanded polytetrafluoroethylene conduits with bulging sinuses and a fan-shaped valve in right ventricular outflow tract reconstruction. J Thorac Cardiovasc Surg 2018;155:2567-76. https://doi.org/10.1016/j.jtcvs.2017.12.137
  19. Si MS. Expanded polytetrafluoroethylene right ventricle to pulmonary artery conduit: time to adopt? J Thorac Cardiovasc Surg 2018;156:1637-8. https://doi.org/10.1016/j.jtcvs.2018.05.020
  20. Kobayashi K, Shinkawa T, Yamagishi M, et al. Right ventricle to pulmonary artery conduit with tricuspid expanded polytetrafluoroethylene valves. Ann Thorac Surg 2021;112:831-7. https://doi.org/10.1016/j.athoracsur.2020.06.119
  21. Ootaki Y, Welch AS, Walsh MJ, Quartermain MD, Williams DA, Ungerleider RM. Medium-term outcomes after implantation of expanded polytetrafluoroethylene valved conduit. Ann Thorac Surg 2018;105:843-50. https://doi.org/10.1016/j.athoracsur.2017.07.013
  22. Kim H, Sung SC, Chang YH, Lee HD, Park JA. A new simplified technique for making tricuspid expanded polytetrafluoroethylene valved conduit for right ventricular outflow reconstruction. Ann Thorac Surg 2013;95:e131-3. https://doi.org/10.1016/j.athoracsur.2012.12.047
  23. Belli E, Salihoglu E, Leobon B, et al. The performance of Hancock porcine-valved Dacron conduit for right ventricular outflow tract reconstruction. Ann Thorac Surg 2010;89:152-8. https://doi.org/10.1016/j.athoracsur.2009.09.046